Insulin/IGF signaling in islet biology and its therapeutic implications
Endocrine Reviews · 16.09.2026 · 47 (5) · 637-665
DOI: 10.1210/endrev/bnag014 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Endocrine Reviews, online erschienen am 20.05.2026. Verfasst von Hyunki Kim und 1 weiteren Autor:innen. Beteiligte Einrichtung: Section of Islet Cell and Regenerative Biology, Joslin Diabetes Center, Boston, MA 02115, USA. Hauptthemen laut MEDLINE: Signal Transduction, Insulin, Islets of Langerhans, Insulin-Like Peptides. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 348 Literaturangaben. Gefördert von: National Research Foundation of Korea (NRF), Ministry of Education, Diabetes Research and Wellness Foundation Endowed Chair.
Abstract (Originalsprache)
The islet of Langerhans (or pancreatic islet) is a unique endocrine organ that secretes multiple hormones that in turn orchestrate energy metabolism in humans. As in other metabolic organs, growth factor(s) regulate functional islet mass to maintain whole-body glucose homeostasis. Over the past decades, a large body of evidence has pointed to insulin and insulin-like growth factors (IGFs) as playing central roles in modulating diverse aspects of islet cell biology and a dysregulated insulin/IGF pathway has come to be recognized as a pathophysiological hallmark of type 2 diabetes. Several recent reports, especially focused on β-cells, highlight emerging aspects of insulin/IGF signaling, including a role for RNA modifications, transcriptional regulation by nuclear insulin and IGF-1 receptors, and the discovery of an insulin inhibitory receptor, inceptor. In this review, we summarize the functional roles of insulin/IGF signaling in regulating islet cell biology, the short- and long-term effects of insulin therapy in humans, and propose potential strategies to maximize the beneficial effects of insulin action in islets to counter diabetes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Section of Islet Cell and Regenerative Biology, Joslin Diabetes Center, Boston, MA 02115, USA.
- Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA.
- Harvard Stem Cell Institute, Harvard Medical School, Cambridge, MA 02138, USA.
ORCID-Profile: Hyunki Kim, Rohit N Kulkarni
Förderung
- National Research Foundation of Korea (NRF)
- Ministry of Education
- Diabetes Research and Wellness Foundation Endowed Chair
- NIDDK NIH HHS
- Joslin Diabetes Research Center (DRC) Cores
- NIH
Zitieren
APA
Kim, H., & Kulkarni, R. N. (2026). Insulin/IGF signaling in islet biology and its therapeutic implications. Endocrine Reviews, 47(5), 637-665. https://doi.org/10.1210/endrev/bnag014
Vancouver
Kim H, Kulkarni RN. Insulin/IGF signaling in islet biology and its therapeutic implications. Endocrine Reviews. 2026;47(5):637-665. doi:10.1210/endrev/bnag014
BibTeX
@article{Kim2026,
author = {Kim, Hyunki and Kulkarni, Rohit N},
title = {Insulin/IGF signaling in islet biology and its therapeutic implications},
journal = {Endocrine Reviews},
year = {2026},
volume = {47},
number = {5},
pages = {637--665},
doi = {10.1210/endrev/bnag014}
}
EUVIMED